Synageva BioPharma Corp (NASDAQ:GEVA)

Monday’s trading has closed, but GEVA is being traded in the after-hours session. After-Hours quote »
102.59
Delayed Data
As of 3:59pm ET
 -5.92 / -5.46%
Today’s Change
60.19
Today|||52-Week Range
122.88
+10.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues2.1M15.0M13.4M6.5M
 
 
 
 
 
Depreciation And Amortization999.8K4.3M5.6M6.1M
 
 
 
 
 
 
Operating ExpensesGross Income1.1M------
 
 
General Expenses26.1M53.7M101.2M189.1M
 
 
 
 
 
Research And Development17.8M37.3M73.7M125.9M
 
 
 
 
 
Total Operating Expenses27.1M58.0M106.8M195.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.0M-43.0M-93.4M-188.6M
 
 
 
 
 
Extraordinary Charge0.000.00-2.5M-3.5M
 
 
 
Pre-Tax Equity Earnings0.00--0.00-600.0K
 
 
Interest Expense On Debt33.5K0.000.00200.0K
 
 
 
Other Expenses-258.5K0.00159.0K362.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.3M-42.9M-95.4M-192.1M
 
 
 
 
 
Income Taxes0.000.00-48.0K-540.0K
 
 
 
Net Income-25.3M-42.9M-95.5M-192.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M22.6M28.1M32.7M
 
 
 
 
 
Shares To Calculate EPS Diluted3.0M22.6M28.1M32.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$8.58-$1.90-$3.40-$5.89
 
 
 
 
 
EPS Diluted-$8.58-$1.90-$3.40-$5.89
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account